SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-013645
Filing Date
2013-03-01
Accepted
2013-03-01 16:55:53
Documents
1
Period of Report
2013-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd372379.html 3  
1 FORM 3 rrd372379.xml 3 3523
  Complete submission text file 0001181431-13-013645.txt   4890
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Kontulis Caitlin (Reporting) CIK: 0001570511 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54910 | Film No.: 13658634